Evidence map›Paper›PMID 36906662›Full record

ArticleNature communications2023

A cybergenetic framework for engineering intein-mediated integral feedback control systems.

Stanislav Anastassov, Maurice Filo, Ching-Hsiang Chang, Mustafa Khammash

Full text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Programming Next-Generation Synthetic Biosensors by Genetic Circuit Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Perspectives on Synthetic Protein Circuits in Mammalian Cells.Current opinion in biomedical engineering · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Regulation strategies for two-output biomolecular networks.Journal of the Royal Society, Interface · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stanislav Anastassov *Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.ORCID 0000-0001-6399-2092
Maurice Filo *Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.ORCID 0000-0002-4556-2336
Ching-Hsiang ChangDepartment of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
Mustafa KhammashDepartment of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland. mustafa.khammash@bsse.ethz.ch.ORCID 0000-0002-4855-9220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of biological systems to tightly regulate targeted variables, despite external and internal disturbances, is known as Robust Perfect Adaptation (RPA). Achieved frequently through biomolecular integral feedback controllers at the cellular level, RPA has important implications for biotechnology and its various applications. In this study, we identify inteins as a versatile class of genetic components suitable for implementing these controllers and present a systematic approach for their design. We develop a theoretical foundation for screening intein-based RPA-achieving controllers and a simplified approach for modeling them. We then genetically engineer and test intein-based controllers using commonly used transcription factors in mammalian cells and demonstrate their exceptional adaptation properties over a wide dynamic range. The small size, flexibility, and applicability of inteins across life forms allow us to create a diversity of genetic RPA-achieving integral feedback control systems that can be used in various applications, including metabolic engineering and cell-based therapy.

Indexed as

InteinsProtein SplicingAnimalsBiotechnologyFeedbackMammals

Identifiers

PMID36906662
PMCPMC10008564

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.